首页>
外国专利>
INHIBITORS OF CREB-CBP INTERACTION FOR TREATMENT OF LEUKEMIA
INHIBITORS OF CREB-CBP INTERACTION FOR TREATMENT OF LEUKEMIA
展开▼
机译:CREB-CBP相互作用对白血病治疗的抑制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
Compounds and methods are provided for inhibiting a CREB-CBP protein-protein interaction in a sample. In some cases, the method includes modulating transcription of CREB in a cell that overexpresses CREB. Also provided are methods of inhibiting the proliferation of a cancer cell. The subject CREB transcription inhibitor compounds include a substituted salicylamide or a prodrug thereof. Methods of alleviating symptoms associated with cancer (e.g., Acute Myeloid Leukemia (AML) or Acute Lymphomblastic Leukemia (ALL)) in a subject in need thereof are also provided. Pharmaceutical compositions including the subject compounds find use in treating cancer. The subject compounds may be formulated or provided to a subject in combination with a second agent, e.g. an anticancer agent.
展开▼